Background Adipose tissue is the most abundant endocrine tissue in the body, producing leptin, a hormone important in regulating hunger, and adiponectin, a hormone involved in insulin sensitivity and inflammation. This study aimed to assess the impact of gastric bypass surgery (GBS) on leptin levels and its relation to the adipose tissue expression of adiponectin. Methods Omental and subcutaneous adipose tissue and serum were obtained from 40 obese patients undergoing GBS, from 13 patients 1 year or more after GBS, and from 16 non-obese individuals with a body mass index of 20 to 29 kg/m 2 . Adiponectin gene expression was measured by quantitative real-time polymerase chain reaction, and the gene expression was normalized for the GAPDH gene. Serum leptin and adiponectin were measured by a highsensitivity enzymatic assay. Results Leptin levels were significantly lower in the post-GBS patients (19.8 ± 6.7) than in the pre-GBS patients (59.0 ± 5.1; P = 0.0001), and similar to those in the nonobese control subjects (18.2 ± 4; P = 0.8). Univariate analysis showed an inverse correlation between serum leptin levels and omental adiponectin gene expression (r = -0.32; P = 0.01). Conclusions Gastric bypass surgery results in resolution of the leptin resistance status that characterizes obese subjects. The study also demonstrated a significant correlation between leptin and adiponectin. This correlation provides preliminary evidence for studying a potential adiponectin-leptin cross-talking that may represent one of the physiologic pathways responsible for the regulation of food intake in humans.
Adipose tissue, the most abundant endocrine tissue in the body, produces several peptides named adipokines [1] . Among them, the two most important are leptin and adiponectin. Leptin is 16 kDa protein encoded by the ob gene in mice (LEP in humans) and secreted by adipose tissue in circadian pulsatile fashion [2] . Leptin plays a key role in regulating energy intake and energy expenditure, including appetite and metabolism [2] . Adiponectin is a 247-aminoacids protein consisting of four domains with a molecular weight of 30 kDa that have insulin-sensitizing, anti-atherogenic, and antiinflammatory actions [3] . Circulating concentrations of adiponectin are decreased in subjects with obesity, type 2 diabetes, hypertension, dyslipidemia, and cardiovascular disease compared with healthy individuals [3] . In 2008, Fain et al. [4] , using omental adipose tissue explants, determined that adiponectin release is reduced by obesity.
Until recently, there was no evidence of interaction between leptin and adiponectin pathways. In 2004, Minokoshi et al. [5] demonstrated in mice that leptin inhibits adenosine monophosphate-activated protein kinase (AMPK) activity in the hypothalamus and thereby reduces food intake. Based on these findings, Kubota et al. [6] used mice to investigate the effect of adiponectin on the leptin-induced suppression of AMPK activity in the hypothalamus. In their study, they demonstrated that both adiponectin receptors AdipoR1 and AdipoR2 were abundantly expressed in the hypothalamus, with expression levels similar to those in the liver. In situ hybridization showed that adiponectin and the leptin receptors are located in the same region of the hypothalamus. The work of Kubota et al. [6] also was fundamental in demonstrating that after intravenous infusion of adiponectin, the peptide can cross the hematoencephalic barrier in the hexamer and trimer forms. Their key finding was that adiponectin and leptin modulate the AMPK phosphorylation in the hypothalamus. They concluded that the central adiponectin-leptin signaling represents the physiologic pathway by which hypothalamic AMPK activity and food intake are stimulated under fasting conditions and suppressed by refeeding.
Currently, there are limited evidences of interaction between leptin and adiponectin systems in humans. The only published study focused on a human disease that is the opposite of obesity: anorexia nervosa [7] . In this study, adiponectin levels were inversely correlated with leptin levels and body mass index (BMI) during in-hospital refeeding without reaching statistical significance [7] .
In our study, we hypothesized that the central adiponectin-leptin signaling represents the physiologic pathway responsible for the anorexia observed after gastric bypass surgery (GBS). To test the hypothesis that this pathway is important in the pathogenesis of human obesity, we assessed the impact of GBS on leptin levels and its relation to serum and adipose tissue adiponectin levels.
Methods
After institutional review board approval, 69 study participants were enrolled in the study. This cohort of participants was divided in three groups: (1) post-GBS subjects (with at least 12 months of follow-up evaluation) undergoing an elective abdominal surgical procedure (e.g., cholecystectomy, abdominal wall hernia repair, or abdominoplasty), (2) subjects with class 2 or 3 obesity undergoing GBS, and (3) non-obese control subjects (BMI, 20-29 kg/m 2 ) require an elective abdominal surgery. The exclusion criteria for the study ruled out all patients with a diagnosis of neoplastic disease, inflammatory bowel disease, acute cholecystitis, or pregnancy.
During the surgical procedure, immediately after entrance to the abdominal cavity, two abdominal subcutaneous and intraabdominal omental fat tissue biopsies smaller than 0.5 cm 3 were obtained. The tissue samples were washed in phosphate-buffered saline (PBS) solution, then soaked in RNAlater preservative solution (Qiagen; Courtaboeuf, France) and stored at -80°C. All the samples were stored in the same -80°C freezer and then analyzed together. Total RNA was extracted from the adipose tissue biopsies using the Lipideasy total RNA Mini kit (Qiagen). The integrity of total RNA was checked by electrophoresis through an agarose gel. Adiponectin gene expression was studied by quantitative, real-time reverse transcriptase-polymerase chain reaction (RT-PCR) using the specific protocol for the iCycler iQ Detection System (BioRad, Hercules, CA, USA) with SYBR green fluorophore. Reactions were performed in a total volume of 20 ll including 10 ll of 29 SYBR Green PCR Master Mix (BioRad), 1 ll of each primer at 5 lmol/l concentration, and 1 ll of the previously reverse-transcribed cDNA template. The PCR primer sequence for adiponectin and GAPDH was chosen based on the sequences available in GenBank (www.ncbi.nlm.nih.gov/Genbank). Melting curves were used to determine the specificity of the gene products, which was subsequently confirmed by running the PCR products on agarose gels. The threshold cycle value for each reaction, reflecting the amount of PCR needed to identify a target gene, was calculated. Specimens were run in duplicate, and the threshold cycle values were averaged. As an internal control housekeeping gene, GAPDH was used to normalize the PCRs for the amount of RNA added to the reverse transcription reactions.
A fasting blood sample also was obtained from each subject immediately before the induction of general anesthesia and promptly spun in a refrigerated (4°C) centrifuge at 3,000 rpm for 10 min. The extracted plasma was used for adiponectin and leptin determinations by high-sensitivity enzyme-linked immunosorbent assay (ELISA).
Statistical analysis
Continuous variables between the groups were compared using unpaired Student's t tests. Categorical variables were compared using the chi-square test or Fisher's exact test. Variables that showed a significant univariate correlation were confirmed to be independent in a multiple stepwise regression model to adjust for potential confounding factors. The SPSS statistical software program, version 15.0 (SPSS, Chicago, IL, USA) was used for all analyses. All tests were two-tailed, and all P values less than 0.05 were considered to indicate statistical significance.
Results
Abdominal adipose tissues and plasma were obtained from 40 obese subjects undergoing GBS, 16 non-obese subjects, and 13 post-GBS subjects who had been followed up for 19 months.
As shown in Table 1 , the three groups showed no significant differences in terms of mean age. The post-GBS group was characterized by a significantly higher percentage of female subjects than the nonobese group. Obviously, by study design, the post-GBS and nonobese groups had a mean BMI significantly lower than the obese group (P = 0.001).
As shown in Fig. 1 , the serum leptin levels for the post-GBS patients were significantly lower than for the obese patients (P \ 0.001) but similar to the levels of the nonobese control subjects. Figure 2 depicts the total serum adiponectin levels in the three groups. The post-GBS group had significantly higher levels of adiponectin than the obese group (P = 0.004).
As shown in Fig. 3 , the adiponectin gene expression in the omental adipose tissues differed significantly among the three groups. On the other hand, the three groups showed similar levels of adiponectin gene expression in the subcutaneous adipose tissue samples.
The correlation plot analysis shown in Fig. 4 that includes all three groups demonstrates a significant inverse correlation between serum leptin levels and omental adiponectin expression (r = -0.32; P = 0.01). This univariate correlation was confirmed to be independent in a multiple stepwise regression model for prediction of leptin after adjustment for confounding factors (BMI and age).
Data analysis showed no significant correlation between serum leptin and subcutaneous adiponectin gene expression (r = -0.20; P = 0.1). Likewise, no significant correlation was observed between serum leptin and serum adiponectin (r = -0.14; P = 0.2).
Discussion
In the current study, GBS resulted in resolution of the leptin resistance status that characterizes obese subjects and upregulation of the adiponectin gene expression in the visceral fat. We also demonstrated in the entire cohort of patients enrolled in the study a significant correlation between serum leptin and adiponectin gene expression in the visceral fat. This important correlation provides the basis for further investigations aimed at studying the adiponectin-leptin cross-talking as one of the physiologic pathways responsible for the regulation of food intake in humans.
Adipose tissue is a complex, essential, and highly active metabolic and endocrine organ. Adipose tissue not only responds to afferent signals from traditional hormone systems and the central nervous system but also expresses and secretes factors with important endocrine functions [8] . These factors include leptin and adiponectin. Fain et al. [9] have demonstrated that leptin and adiponectin are mainly secreted by adipocytes, whereas other adipokines are secreted by the stromal vascular fraction of the adipose tissue. Until few years ago, these two proteins were thought to have no interaction, with only leptin active on the hypothalamus [10, 11] . A previous study in mice has shown that adiponectin stimulates fatty acid oxidation and enhances insulin sensitivity through the activation of AMPK in the peripheral tissues [12] . However, the effects of adiponectin in the central nervous system was poorly understood until 2007, when Kubota et al. [6] discovered that adiponectin stimulates AMPK in the hypothalamus and increases food intake. Before this pivotal study, adiponectin was not thought to have a key role in regulating energy intake and energy expenditure. Because leptin is reported to inhibit AMPK activity in the hypothalamus and thereby to suppress food intake [5] , Kubota et al. [6] also investigated the effect of adiponectin on the leptin-induced suppression of AMPK activity in the hypothalamus. Their key finding was that the leptin-induced AMPK phosphorylation suppression in the hypothalamus was significantly reversed by intravenous injection of adiponectin [6] . Recently, these results also were validated by a study of Coope et al. [13] in which intracerebroventricular injection of recombinant rat adiponectin promoted an anorexigenic condition in rats with a 40% reduction in food intake and activated signal transduction through the classical insulin-and leptin-signaling pathways.
Preliminary evidence of interaction between the adiponectin and leptin systems also was provided by a study investigating serum adiponectin and leptin levels in subjects with anorexia nervosa [7] . In this study, serum adiponectin levels were inversely correlated with leptin levels and BMI during in-hospital refeeding. This finding corroborates the results of a previous animal study suggesting that adiponectin might have a role in maintaining energy homeostasis under energy shortage conditions [14] .
Several studies have shown resolution of the leptinresistance status after bariatric surgery procedures [15] [16] [17] [18] [19] . Serum adiponectin also is well known to increase significantly after weight loss induced by bariatric surgery [20] [21] [22] .
In contrast, very few studies have focused on the adiponectin gene expression in adipose tissue before and after bariatric surgery [20, 23] . However, in all these studies, samples were taken only from the subcutaneous fat depot. Our study was innovative in that it included a determination of adiponectin gene expression in the visceral fat before and after GBS, and more importantly, we were able to demonstrate for the first time in humans a significant correlation between omental adiponectin and serum leptin.
Our current findings support the hypothesis that high levels of circulating adiponectin combined with a low level of leptin may be responsible for the anorexia observed after GBS [24] . Further studies using a rodent model of GBS are needed to confirm that increased postoperative adiponectin levels enhance AMPK activity in the arcuate hypothalamus via its receptor to regulate food intake. 
